JOURNAL OF GENE MEDICINE

JOURNAL OF GENE MEDICINE

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2025-06-02

13f4a2d1m65暂无昵称

来自重庆

偏重的研究方向:基因经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人

16

0

举报

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2025-03-08

13f4a2d1m65暂无昵称

来自瑞典

偏重的研究方向:基因经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人

20

0

举报

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2024-03-24

zhangqiccmu

来自湖北省

审稿速度:2.0 | 投稿命中率:25.0偏重的研究方向:妇科肿瘤经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。

107

2

举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2024-11-20

匿名用户

1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样

47

0

举报

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2024-11-16

ms1000001202704844

来自重庆

偏重的研究方向:基因经验分享:一个月没有审稿人,被拒了,着急毕业的慎投

37

0

举报

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2024-08-14

洛洛仔111

来自湖南省

初审差不多两个月,没人审稿,悲剧

97

0

举报

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2024-02-18

扒坏蛋糕

来自上海

审稿速度:6.0偏重的研究方向:胰腺炎经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了

106

1

举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2023-03-22

14862b90m09(暂无昵称)

来自上海

请问各位初审Under Review多久

112

3

举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2020-05-16

14697858m50(暂无昵称)

投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考

227

2

举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267623, encodeId=ce0c226e623c4, content=偏重的研究方向:基因
经验分享:3月8号投,6月1日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Mon Jun 02 07:25:18 CST 2025, time=2025-06-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2255246, encodeId=7c17225524659, content=偏重的研究方向:基因
经验分享:1月25日投稿,3月8日拒稿,原因:找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2a4307233, createdName=13f4a2d1m65暂无昵称, createdTime=Sat Mar 08 22:01:50 CST 2025, time=2025-03-08, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向:妇科肿瘤
经验分享:投了第二天旧送审了,2.5送审,3.11悲剧,理由:找了三十个审稿人,没人审稿,真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2237959, encodeId=6ae9223e959ad, content=1.如果没有机构邮箱的话需要在稿件中注明:institutional email : not available

2.手稿中数据声明需要从期刊模板中选择,必须和模板一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Nov 20 11:43:56 CST 2024, time=2024-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237234, encodeId=f5d8223e234cf, content=偏重的研究方向:基因
经验分享:一个月没有审稿人,被拒了,着急毕业的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72369359952, createdName=ms1000001202704844, createdTime=Sat Nov 16 11:01:19 CST 2024, time=2024-11-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月,没人审稿,悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0
偏重的研究方向:胰腺炎
经验分享:审稿速度非常慢,一审2个月,2审3个月还在进行中,且发邮件不回复,太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信,被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海)]

2022-12-27

ms1000001212608631

来自上海

挺好的杂志,做外泌体miRNA治疗方向,投了别的五六分期刊都被拒了,投这个至少给外审了,希望能有好结果

119

0

举报

相关推荐

艺龙威胁到携程了吗?   两家企业是同盟还是死对头,通常是个很简单的问题。但对$携程(CTRP)$ 和$艺龙(LONG)$ 来说,二者关系却更...
供精条件、费用与流程
365bet线上投注

供精条件、费用与流程

📅 07-11 👁️ 3216
HIFIDIY论坛
365bet安全上网导航

HIFIDIY论坛

📅 07-09 👁️ 6148